Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2053-6844
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana ; volume:4 ; number:1 ; day:3 ; month:3 ; year:2017 ; pages:1-7 ; date:12.2017
Gynecologic oncology research and practice ; 4, Heft 1 (3.3.2017), 1-7, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Obiri-Yeboah, Dorcas
- Beteiligte Personen und Organisationen
-
Adu-Sarkodie, Yaw
Djigma, Florencia
Akakpo, Kafui
Aniakwa-Bonsu, Ebenezer
Amoako-Sakyi, Daniel
Simpore, Jacques
Mayaud, Philippe
SpringerLink (Online service)
- DOI
-
10.1186/s40661-017-0041-1
- URN
-
urn:nbn:de:1111-2017052819623
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Obiri-Yeboah, Dorcas
- Adu-Sarkodie, Yaw
- Djigma, Florencia
- Akakpo, Kafui
- Aniakwa-Bonsu, Ebenezer
- Amoako-Sakyi, Daniel
- Simpore, Jacques
- Mayaud, Philippe
- SpringerLink (Online service)
Ähnliche Objekte (12)
An economical Nanopore sequencing assay for human papillomavirus (HPV) genotyping
Analytical Evaluation of the Human Papillomavirus HPV DNA Array E1-Based Genotyping Assay
Erratum to: Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana
Evaluation of using composite HPV genotyping assay results to monitor human papillomavirus infection burden through simulation
CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology
Analytical and clinical evaluation of the HPV DNA Array E1-based genotyping assay
Multiplex HPV RNA in situ hybridization/p16 immunohistochemistry: a novel approach to detect papillomavirus in HPV-related cancers. A novel multiplex ISH/IHC assay to detect HPV
Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer
Genotyping of high-risk anal human papillomavirus (HPV): ion torrent-next generation sequencing vs. linear array
Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
A comprehensive HPV-STI NGS assay for detection of 29 HPV types and 14 non-HPV sexually transmitted infections
Correction: Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
An economical Nanopore sequencing assay for human papillomavirus (HPV) genotyping
Analytical Evaluation of the Human Papillomavirus HPV DNA Array E1-Based Genotyping Assay
Erratum to: Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana
Evaluation of using composite HPV genotyping assay results to monitor human papillomavirus infection burden through simulation
CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology
Analytical and clinical evaluation of the HPV DNA Array E1-based genotyping assay
Multiplex HPV RNA in situ hybridization/p16 immunohistochemistry: a novel approach to detect papillomavirus in HPV-related cancers. A novel multiplex ISH/IHC assay to detect HPV
Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer
Genotyping of high-risk anal human papillomavirus (HPV): ion torrent-next generation sequencing vs. linear array
Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
A comprehensive HPV-STI NGS assay for detection of 29 HPV types and 14 non-HPV sexually transmitted infections
Correction: Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
An economical Nanopore sequencing assay for human papillomavirus (HPV) genotyping
Analytical Evaluation of the Human Papillomavirus HPV DNA Array E1-Based Genotyping Assay
Erratum to: Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana
Evaluation of using composite HPV genotyping assay results to monitor human papillomavirus infection burden through simulation
CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology
Analytical and clinical evaluation of the HPV DNA Array E1-based genotyping assay
Multiplex HPV RNA in situ hybridization/p16 immunohistochemistry: a novel approach to detect papillomavirus in HPV-related cancers. A novel multiplex ISH/IHC assay to detect HPV
Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer
Genotyping of high-risk anal human papillomavirus (HPV): ion torrent-next generation sequencing vs. linear array
Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
A comprehensive HPV-STI NGS assay for detection of 29 HPV types and 14 non-HPV sexually transmitted infections